Evidence map›Paper›PMID 33269341›Full record

ArticleChemRxiv : the preprint server for chemistry2020

COVID-19 Knowledge Extractor (COKE): A Tool and a Web Portal to Extract Drug - Target Protein Associations from the CORD-19 Corpus of Scientific Publications on COVID-19.

Daniel Korn, Vera Pervitsky, Tesia Bobrowski, Vinicius M Alves, Charles Schmitt, Chris Bizon, Nancy Baker, Rada Chirkova, Artem Cherkasov, Eugene Muratov and 1 more

Open access · greenAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in ChemRxiv : the preprint server for chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Daniel KornDepartment of Computer Science, the University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
Vera PervitskyLaboratory for Molecular Modeling, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, the University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
Tesia BobrowskiLaboratory for Molecular Modeling, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, the University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
Vinicius M AlvesOffice of Data Science, National Toxicology Program, NIEHS, Morrisville, NC, 27560, USA.
Charles SchmittOffice of Data Science, National Toxicology Program, NIEHS, Morrisville, NC, 27560, USA.
Chris BizonRenaissance Computing Institute, the University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7568, USA.
Nancy BakerParlezChem, 123 W Union Street, Hillsborough, NC, 27278, USA.
Rada ChirkovaDepartment of Computer Science, North Carolina State University, Raleigh, NC, 27606-5550.
Artem CherkasovVancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
Eugene MuratovLaboratory for Molecular Modeling, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, the University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
Alexander TropshaLaboratory for Molecular Modeling, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, the University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
University of North Carolina at Chapel Hill · USResearch Triangle Park Foundation · USNorth Carolina State University · USRenaissance Computing Institute · USUnion Hospital · CNUniversity of British Columbia · CA

Funding

ARAGORN: Autonomous Relay Agent for Generation Of Ranked NetworksOT2TR003441 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TROPSHA, ALEXANDER · 2020 to 2024
$4.7M
Drug Repurposing for Cancer Therapy: From Man to Molecules to ManU01CA207160 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TROPSHA, ALEXANDER · 2016 to 2018
$1.2M
NCATS NIH HHS OT2 TR003441NCI NIH HHS U01 CA207160
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CORD-19COVID-19COVID-19 dataDrug-target-disease associationsknowledge acquisitiontext mining

Identifiers

PMID33269341
PMCPMC7709174
OpenAlexW3108563815

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.